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Summary
A	total	of	2,571	barrows	and	gilts	(PIC	337	×	1050)	were	used	to	determine	the	effects	
of	porcine	circovirus	type	2	vaccine	(PCV2)	on	nursery	and	finishing	pigs	that	were	
challenged	with	porcine	respiratory	and	reproductive	syndrome	(PRRS).	Treatments	
were	arranged	in	a	2	×	2	factorial	design	with	main	effects	of	gender	(barrow	or	gilt)	
and	vaccine	(PCV2	vaccinates	or	non-vaccinates).	Vaccinated	pens	received	2	doses	of	
commercial	PCV2	vaccine	(Circumvent	PCV,	Intervet	Inc.,	Millsboro,	DE)	according	
to	label	directions	on	d	1	and	22	in	the	nursery.	All	pigs	were	also	inoculated	on	d	30	
with	serum	containing	PRRS	virus	as	part	of	this	production	system’s	protocol.	Barns	
were	double	stocked	from	d	0	to	51.	On	d	51,	gilts	were	moved	to	an	adjacent	facility	
and	barrows	were	split	into	2	pens.	
In	the	period	after	the	initial	PCV2	vaccination	(d	0	to	15),	no	difference	in	ADG,	
ADFI,	or	F/G	was	observed	(P >	0.13)	between	genders	or	between	vaccinates	and	
non-vaccinates.	However,	in	the	period	after	the	second	PCV2	vaccination	(d	15	to	
29),	vaccinated	pigs	had	decreased	(P <	0.02)	ADG	compared	with	non-vaccinates	as	
a	result	of	decreased	(P <	0.04)	ADFI.	Gilts	also	had	increased	(P <	0.04)	ADG	and	
ADFI	compared	with	barrows.	In	the	period	after	all	pigs	were	inoculated	with	PRRS	
virus	(d	29	to	50),	PCV2	vaccinates	had	improved	(P <	0.001)	F/G	over	non-vaccinates	
and	a	trend	(P <	0.08)	for	improved	ADG.	Gilts	had	poorer	(P <	0.01)	F/G	compared	
with	barrows	from	d	29	to	50.	Over	the	entire	50-d	nursery	portion	of	the	study,	no	
differences	were	observed	(P >	0.61)	for	ADG,	ADFI,	or	final	weight	among	gender	or	
PCV2	vaccinates	and	non-vaccinates.	However,	F/G	was	improved	(P <	0.001)	with	
PCV2	vaccination.
Pig	weights	on	d	71	and	99	were	increased	(P	<	0.001)	in	vaccinates	compared	with	
non-vaccinates,	and	barrows	had	increased	(P	<	0.001)	BW	compared	with	gilts	
on	d	99.	At	the	conclusion	of	the	study	(d	132	for	barrows	and	d	142	for	gilts),	the	
percentage	of	pigs	remaining	on	test	was	decreased	(P	<	0.001)	in	non-vaccinated	pens	
compared	with	vaccinated	pens	(70.2%	vs.	94.7%,	respectively).	This	study	suggests	that	
despite	the	decrease	in	performance	related	to	the	second	vaccination	of	PCV2,	the	
second	vaccination	improved	final	performance	and	decreased	the	number	of	removals	
due	to	the	PRRS	health	challenge.	
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Introduction
Porcine	circovirus	disease	(PCVD)	caused	by	porcine	circovirus	type	2	(PCV2)	has	
recently	become	a	major	disease	affecting	growing	pigs	worldwide.	Several	commer-
cial	PCV2	vaccines	are	available	to	decrease	the	impact	of	PCVD.	Recent	research	has	
shown	increases	in	growth	rates	and	finals	weights	of	finishing	pigs	vaccinated	with	
PCV2	vaccine	(Jacela	et	al.,	20075,	20086;	Potter	et	al.,	20087).	However,	Kane	et	al.	
(20088)	reported	a	decrease	in	nursery	pig	ADG	due	to	decreases	in	feed	intake	after	
vaccination	for	PCV2	and	Mycoplasma hyopneumoniae.	This	indicates	that	although	
there	may	be	improvements	in	finishing	pig	performance	with	PCV2	vaccination,	there	
may	be	some	expense	due	to	lost	nursery	performance.	Additional	health	challenges	
could	also	affect	the	response	to	PCV2	vaccination.	The	objective	of	this	study	was	to	
determine	the	effects	of	PCV2	vaccination	in	gilts	and	barrows	challenged	with	porcine	
respiratory	and	reproductive	syndrome	(PRRS).	
Procedures
Procedures	in	this	experiment	were	approved	by	the	Kansas	State	University	Institu-
tional	Animal	Care	and	Use	Committee.	The	experiment	was	conducted	at	a	commer-
cial	research	finishing	facility	in	southwestern	Minnesota.	The	facility	was	double	
curtain	sided	with	completely	slatted	flooring.	Pens	were	10	×	18	ft	and	were	equipped	
with	a	5-hole	conventional	dry	feeder	and	a	cup	waterer.	
A	total	of	2,571	barrows	and	gilts	(PIC	337	×	1050,	initially	12.6	lb)	were	weaned	
into	a	wean-to-finish	facility.	Pens	were	double	stocked	with	56	pigs	per	pen,	and	gilts	
and	barrows	were	penned	separately.	A	total	of	46	pens	were	used;	24	pens	contained	
barrows,	and	22	pens	contained	gilts.	All	pigs	were	vaccinated	for	M. hyopneumoniae	
while	in	the	farrowing	facility.	The	PCV2	vaccination	treatments	were	then	allotted	
by	pen	at	placement	to	both	barrow	and	gilt	pens	in	a	completely	randomized	design.	
Vaccine	treatments	included	either	no	PCV2	vaccine	or	vaccination	with	2	doses	of	
commercial	PCV2	vaccine	(Circumvent	PCV,	Intervet	Inc.,	Millsboro,	DE)	given	
according	to	label	directions	on	d	1	and	d	22.	All	pigs	were	then	inoculated	with	serum	
containing	PRRS	virus	on	d	30	as	part	of	this	production	system’s	protocol.	On	d	51,	
gilts	pens	were	moved	to	an	adjacent	barn	of	similar	design.	Pen	integrity	was	main-
tained	for	gilt	pens,	and	the	original	pen	was	split	into	2.	Once	all	gilt	pens	were	moved,	
a	gate	cut	of	half	of	each	barrow	pen	was	moved	to	an	empty	pen	in	the	wean-to-finish	
barn.	Thus,	similar	to	gilts,	the	pen	integrity	was	maintained	across	the	2	pens.		 	
Pig	weights	(by	pen),	feed	disappearance,	and	pen	head	counts	were	measured	through-
out	the	nursery	portion	of	the	experiment	to	determine	ADG,	ADFI,	and	F/G	for	each	
pen.	After	the	conclusion	of	the	nursery	portion	and	pigs	were	split	between	barns,	pen	
counts	were	determined	on	d	71,	99,	and	at	the	conclusion	of	the	study	(d	132	and	142	
for	the	barrow	and	gilt	barns,	respectively).	Pen	head	counts	from	both	the	nursery	and	
finishing	phases	were	compared	with	the	starting	original	pen	count	to	determine	the	
percentage	of	pigs	remaining.	Pig	weights	(by	pen)	were	also	determined	on	d	71	and	
99;	however,	weights	were	not	obtained	on	d	132	and	142	for	the	barrow	and	gilt	barns,	
5	Jacela	et	al.,	Swine	Day	2007,	Report	of	Progress	985,	pp.	5-9.
6	Jacela	et	al.,	Swine	Day	2007,	Report	of	Progress	985,	pp.	10-16.
7	Potter	et	al.,	Swine	Day	2008,	Report	of	Progress	1001,	pp.	5-13.
8	Kane	et	al.,	Swine	Day	2008,	Report	of	Progress	1001,	pp.	14-20.
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respectively.	These	same	pigs	were	used	in	2	lysine	trials	during	the	finishing	phase	
from	d	71	to	99	with	dietary	treatments	equally	allotted	across	vaccine	treatments	in	
a	balanced	design.	To	limit	the	effect	of	pig	space	for	the	lysine	trials,	a	portion	of	the	
PCV2-vaccinated	pigs	were	removed	from	pens	on	d	132	and	142	for	the	barrow	and	
gilt	barns,	respectively,	which	is	the	reason	this	trial	ended	on	those	particular	days.	
Therefore,	during	the	trial,	pigs	were	removed	only	for	poor	health.	
	
Data	were	then	analyzed	for	each	experiment	as	a	2	×	2	factorial	design	(with	or	with-
out	PCV2	vaccine	and	gender).	The	nursery	and	finishing	growth	and	weight	responses	
were	analyzed	using	the	PROC	MIXED	procedure	in	SAS	(SAS	Institute	Inc.,	Cary,	
NC).	The	percentage	of	remaining	pigs	was	analyzed	using	the	PROC	GENMOD	
procedure	in	SAS.	The	original	pen	was	used	as	the	experimental	unit	in	all	analyses.	
Results and Discussion
From	d	0	to	15,	no	difference	in	ADG,	ADFI,	or	F/G	was	observed	(P >	0.13)	between	
genders	or	between	vaccinates	and	non-vaccinates,	indicating	that	the	first	injection	of	
PCV2	vaccine	did	not	affect	performance	(Table	1).	However,	in	the	period	after	the	
second	injection	(d	15	to	29),	PCV2-vaccinated	pigs	had	decreased	(P <	0.02)	ADG	
compared	with	non-vaccinates.	This	appears	to	be	a	result	of	decreased	(P <	0.04)	
ADFI.	Gilts	had	increased	(P <	0.04)	ADG	and	ADFI	compared	with	barrows.	A	trend	
was	also	detected	(P <	0.07)	for	a	gender	×	vaccine	interaction	for	F/G	from	d	15	to	
29.	This	interaction	was	due	to	a	slightly	poorer	F/G	among	vaccinated	barrows	and	a	
slight	improvement	among	vaccinated	gilts.	However,	in	the	period	after	inoculation	
with	PRRS	virus	(d	29	to	50),	PCV2	vaccinates	had	improved	(P <	0.001)	F/G	and	a	
trend	for	increased	(P <	0.08)	ADG	compared	with	non-vaccinates.	Gilts	had	poorer	
(P <	0.01)	F/G	compared	with	barrows	from	d	29	to	50.	Over	the	entire	50-d	nursery	
portion	of	the	study,	no	difference	was	detected	(P >	0.61)	for	ADG,	ADFI,	or	final	
weight	between	genders	or	between	PCV2	vaccinates	and	non-vaccinates.	However,	
F/G	was	improved	(P <	0.001)	with	PCV2	vaccination	and	improved	(P <	0.001)	for	
barrows	compared	with	gilts.
Although	there	was	no	difference	in	final	weight	after	the	nursery	portion	on	d	50,	pig	
weights	on	d	71	and	99	were	greater	(P <	0.001)	in	PCV2	vaccinates	than	in	non-vacci-
nates.	Barrows	had	increased	(P <	0.001)	BW	comparison	with	gilts	on	d	99.	
No	differences	were	observed	(P >	0.37)	in	the	percentage	of	pigs	remaining	in	pens	
throughout	the	nursery	portion	of	the	study	(d	15,	29,	or	50;	Table	2).	However,	the	
percentage	of	pigs	remaining	on	test	was	reduced	(P <	0.001)	in	non-vaccinated	pens	
compared	with	vaccinated	pens	on	d	71,	99,	and	d	132	and	142	for	the	barrow	and	gilt	
barns,	respectively.	The	majority	of	these	removals	were	unthrifty	appearing	pigs.	Only	
5	of	the	non-vaccinated	pigs	showed	clinical	signs	of	PCVD.	Also,	gender	×	vaccine	
interactions	were	detected	(P <	0.07)	for	pigs	remaining	on	d	99	and	on	d	132	and	142	
for	the	barrow	and	gilt	barns,	respectively.	This	interaction	is	a	result	of	more	unvac-
cinated	gilts	pigs	remaining	on	test	compared	with	barrows,	which	had	a	greater	differ-
ence	in	removal	rate	of	non-vaccinates	compared	with	vaccinates.	Despite	the	interac-
tion,	in	barrows	and	gilts,	pigs	remaining	decreased	in	non-vaccinates	compared	with	
vaccinates.
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The	data	from	this	study	suggest	that	when	health	challenges	such	as	inoculation	with	
PRRS	virus	are	present,	PCV2	vaccination	can	improve	final	performance	and	decrease	
the	number	of	removals	related	to	the	particular	health	challenge.	However,	vaccination	
for	PCV2,	especially	the	second	injection,	decreased	feed	intake	and	affected	perfor-
mance	in	the	nursery	stage.	Additional	research	is	needed	to	understand	the	optimal	
vaccine	timing	for	PCV2	vaccination	in	order	to	limit	any	negative	effects	vaccination	
may	have	on	nursery	pig	performance.	
Table 1. Effects of porcine circovirus type 2 (PCV2) vaccination and gender on growth performance1
Barrow Gilt Probability,	P <
PCV2	vaccination: No Yes No Yes SEM
Gender	×	
Vaccine Vaccine Gender
Initial	wt,	lb 12.6 12.6 12.6 12.6 0.37 0.99 0.99 0.99
d	0	to	152
					ADG,	lb 0.59 0.58 0.60 0.59 0.03 0.95 0.93 0.75
					ADFI,	lb 0.87 0.82 0.87 0.86 0.04 0.62 0.46 0.55
					F/G 1.50 1.41 1.49 1.47 0.04 0.33 0.14 0.57
d	15	to	293
					ADG,	lb 0.93 0.89 0.98 0.92 0.02 0.56 0.02 0.04
					ADFI,	lb 1.43 1.36 1.50 1.44 0.04 0.88 0.04 0.04
					F/G 1.55 1.53 1.53 1.56 0.01 0.07 0.82 0.48
d	29	to	504
					ADG,	lb 0.90 0.96 0.84 0.92 0.04 0.85 0.08 0.22
					ADFI,	lb 1.61 1.60 1.56 1.60 0.07 0.66 0.81 0.69
					F/G 1.80 1.66 1.85 1.74 0.02 0.54 0.001 0.01
d	0	to	50
					ADG,	lb 0.81 0.83 0.81 0.82 0.03 0.99 0.62 0.86
					ADFI,	lb 1.34 1.30 1.34 1.33 0.05 0.69 0.63 0.71
					F/G 1.65 1.57 1.66 1.62 0.02 0.10 0.001 0.05
d	50	wt,	lb 53.9 54.1 53.4 54.0 1.76 0.94 0.82 0.88
Finisher	weights5
					d	71	wt,	lb 82.6 90.0 82.1 87.5 1.38 0.47 0.001 0.26
					d	99	wt,	lb 139.3 147.9 130.6 137.1 1.75 0.51 0.001 0.001
1	A	total	of	2,571	barrows	and	gilts	(PIC	337	×	1050)	were	double	stocked	into	a	wean-to-finish	barn	and	observed	for	50	d	to	
determine	the	effects	of	PCV2	vaccine	on	growth	performance.	
2	The	first	PCV2	vaccine	was	given	on	d	1	of	this	study	to	the	selected	pens	of	pigs.	
3	The	second	PCV2	vaccine	was	given	on	d	22	of	the	study	to	the	selected	pens	of	pigs.	
4	All	pigs	were	injected	with	live	PRRS	virus	on	d	30.	
5	Pens	were	split	and	gilts	were	moved	to	another	barn	on	d	51,	and	finisher	weights	were	determined	by	using	both	split	pens.	
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Table 2. Effects of porcine circovirus type 2 (PCV2) vaccination and gender on pig counts1
Barrow Gilt Probability,	P <
PCV2	vaccination: No Yes   No Yes SEM
Gender	×	
Vaccine Vaccine Gender
d	0	pen	count,	no. 55.8 55.8 56.0 56.0
Pigs	remaining,	%
					d	152 99.7 99.5 99.3 99.6 0.31 0.39 0.41 0.76
					d	293 98.8 99.3 99.3 99.1 0.39 0.38 0.74 0.66
					d	504 95.1 98.7 96.2 97.5 1.01 0.25 0.38 0.39
					d	715 79.3 97.3 81.0 96.2 1.82 0.44 0.001 0.68
					d	995 69.9 96.5 76.2 96.0 1.68 0.05 0.001 0.83
Trial	conclusion5,6 65.6 95.3 74.8 94.0 1.91 0.07 0.001 0.62
1	A	total	of	2,571	barrows	and	gilts	were	double	stocked	into	a	wean-to-finish	barn	and	observed	for	50	d	to	determine	the	effects	of	
PCV2	vaccine	on	nursery	growth	performance.	
2	Time	period	after	the	first	PCV2	vaccine	(d	1).	
3	Time	period	after	the	second	PCV2	vaccine	(d	22).	
4	Time	period	after	all	pigs	were	injected	with	live	PRRS	virus	(d	30).	
5	Pens	were	split	and	gilts	were	moved	to	another	barn	on	d	51.	
6	Barrow	barn	on	d	132	and	gilt	barn	on	d	142.
